Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer

Published:2018-07-04 Issue:9 Volume:67 Page:1393-1406
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Barrera Lourdes^ORCID,Montes-Servín Edgar^ORCID,Hernandez-Martinez Juan-Manuel^ORCID,Orozco-Morales Mario,Montes-Servín Elizabeth,Michel-Tello David,Morales-Flores Renato Augusto,Flores-Estrada Diana,Arrieta Oscar^ORCID

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-018-2196-y/fulltext.html

Reference70 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29. https://doi.org/10.3322/caac.21208

2. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359:1367–1380. https://doi.org/10.1056/NEJMra0802714

3. Bremnes RM, Busund LT, Kilvaer TL et al (2016) The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer. J Thorac Oncol 11:789–800. https://doi.org/10.1016/j.jtho.2016.01.015